Review: could Neurontin cause Obstructive Sleep Apnea Syndrome?


Summary

Obstructive sleep apnea syndrome is reported only by a few people who take Neurontin. We study 55,878 people who have side effects while taking Neurontin from FDA and social media. Among them, 2 have Obstructive sleep apnea syndrome. Find out below who they are, when they have Obstructive sleep apnea syndrome and more.

You are not alone

Join a support group for people who take Neurontin and have Obstructive sleep apnea syndrome >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,882 users)

Obstructive Sleep Apnea Syndrome

Obstructive sleep apnea syndrome (a sleep disorder that involves cessation or significant decrease in airflow in the presence of breathing effort) has been reported by people with migraine, confusion, drowsiness, insomnia, numbness and tingling (latest reports from 302 Obstructive sleep apnea syndrome patients).

On Jul, 27, 2016

55,878 people reported to have side effects when taking Neurontin.
Among them, 2 people (0.0%) have Obstructive Sleep Apnea Syndrome


Number of reports submitted per year:

Could Neurontin cause Obstructive sleep apnea syndrome?

Time on Neurontin when people have Obstructive Sleep Apnea Syndrome *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 50 %
  • 10+ years: 0.0 %

Gender of people who have Obstructive Sleep Apnea Syndrome when taking Neurontin *:

  • female: 50 %
  • male: 50 %

Age of people who have Obstructive Sleep Apnea Syndrome when taking Neurontin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

Severity if Obstructive Sleep Apnea Syndrome when taking Neurontin **:

  • least: 0.0 %
  • moderate: 0.0 %
  • severe: 100 %
  • most severe: 0.0 %

How people recovered from Obstructive Sleep Apnea Syndrome **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top conditions involved for these people *:

  • Stuffy Nose (3 people)
  • Hypercholesterolaemia (3 people)
  • Back Pain (3 people)
  • Anxiety Disorder (3 people)
  • Adhd (3 people)

Top co-used drugs for these people *:

  • Paxil (4 people)
  • Synthroid (3 people)
  • Potassium Chloride (3 people)
  • Fish Oil (3 people)
  • Clonazepam (3 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Obstructive sleep apnea syndrome when taking Neurontin?

Browse all side effects of Neurontin

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome

Could your condition cause Obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome

Can you answer these questions?

More questions for: Neurontin, Obstructive sleep apnea syndrome

You may be interested in these reviews

More reviews for: Neurontin, Obstructive sleep apnea syndrome


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.